SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gerald Underwood who wrote (456)10/8/1998 2:17:00 PM
From: Cavalry  Read Replies (1) of 857
 
this saturday and monday will ignite the squeeze on heb, once actual users of ampligen speak at cfs conference not sure if they will make their presentations on saturday or monday 8 am, either way if people dont front run the news on friday by monday we will get back near $10 imo
still love the report asenio wrote how the dr heb mentions couldnt be important because his name was mentioned last not first, asenio didnt even know that head of research project usually gets his name mentioned last not first,
asenio treading very close to getting sued by cfids imo
cav
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext